Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinoma.

[1]  S. Ménard,et al.  Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors , 1991, International journal of cancer.

[2]  I. Ellis,et al.  A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast. , 1991, British Journal of Cancer.

[3]  S. Ménard,et al.  Expression of Two Antigens Defined by Monoclonal Antibodies in Normal, Benign and Malignant Human Mammary Tissues , 1990, Tumori.

[4]  G M Clark,et al.  How to use prognostic factors in axillary node-negative breast cancer patients. , 1990, Journal of the National Cancer Institute.

[5]  C R King,et al.  Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  H. Bingham.  Prognostic value of estrogen and progesterone receptors in operable breast cancer , 1989 .

[7]  G. Bonadonna,et al.  Cell kinetics as a prognostic indicator in node-negative breast cancer. , 1989, European journal of cancer & clinical oncology.

[8]  W. McGuire,et al.  HER-2/neu oncogene protein and prognosis in breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[10]  G M Clark,et al.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.

[11]  E. Szabo,et al.  Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. , 1989, Cancer research.

[12]  S. Ménard,et al.  Monoclonal antibodies as prognostic indicators of tumor progression in breast cancer. , 1988, Advances in experimental medicine and biology.

[13]  S. Ménard,et al.  A Multiparametric Study by Monoclonal Antibodies in Breast Cancer , 1987 .

[14]  R. Ceriani.  Immunological Approaches to the Diagnosis and Therapy of Breast Cancer , 1987, Springer US.

[15]  W. McGuire,et al.  Role of steroid hormone receptors as prognostic factors in primary breast cancer. , 1986, NCI monographs : a publication of the National Cancer Institute.

[16]  R. W. Baldwin,et al.  Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator. , 1985, British medical journal.

[17]  D. Kufe,et al.  Sodium butyrate induction of milk-related antigens in human MCF-7 breast carcinoma cells. , 1984, Cancer research.

[18]  A. Howell,et al.  The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas , 1984, International journal of cancer.

[19]  M. Moore,et al.  Associated effects of sodium butyrate on histone acetylation and estrogen receptor in the human breast cancer cell line MCF-7. , 1984, Biochemical and biophysical research communications.

[20]  S. Ménard,et al.  Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. , 1983, Cancer research.

[21]  K. Horwitz,et al.  Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance , 1982, Cell.

[22]  J. Hicks,et al.  Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells , 1980, Cancer.

[23]  S. Collins,et al.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. , 1978, Proceedings of the National Academy of Sciences of the United States of America.